CNP-201 Clinical Trial Peanut Allergy
Purpose
The main aim of the study is to assess if CNP-201 can reduce inflammation in participants with a peanut allergy who are on a peanut-free diet so that they can safely eat peanuts. All participants will receive CNP-201 or Placebo through the vein on Day 1 and Day 8.
Key Requirements
Age
16-55 years old
Accepts healthy patients
No, participants must have peanut allergy.
Active Clinical Sites
Allergy and Asthma Medical Group and Research Center
5776 Ruffin Rd,
San Diego, CA 92123
Contact Info:
Email: lorinash@allergyandasthma.com
Phone: (1) 858-268-2368 ext 121
Sneeze, Wheeze & Itch Associates, LLC
2010 Jacobssen Drive,
Normal IL 61761
Contact Info:
Email: stephanieoliver@asthma2.com
Phone: (1) 309-452-0995
Centricity Research
99 N. Brice Rd, Suite 260,
Columbus, OH 43213
Contact Info:
Email: samantha.estrada@centricityresearch.com
Phone: (1) 614-501-6164 ext 2006
Vital Prospects Clinical Research Institute
7307 S. Yale Ave, Suite 200,
Tulsa, OK 74136
Contact Info:
Email: Caitlin.sheppard@aaicenter.net
Phone: (1) 918-392-4550 ext 233
Western Sky Medical Research
2121 Wyoming Ave,
El Paso, TX 79903
Contact Info:
Email: lherrera@westernskymed.com
Phone: (1) 915-544-2557
Pharmaceutical Research & Consulting, Inc
5499 Glen Lakes, Dr. Suite 200,
Dallas, TX 75231
Contact Info:
Email: pharmaceuticalresearchc@gmail.com
Phone: (1) 214-361-5555
Clinical Research Partners LLC
7110 Forest Ave, Suite 201,
Richmond, VA 23226
Contact Info:
Email: ako@clinicalresearchrva.com
Phone: (1) 804-250-9867
Seattle Allergy and Asthma Research Institute
9725 Third Ave, NE Suite 500,
Seattle, WA 98115
Contact Info:
Email: jfernandez@seattleallergy.org
Phone: (1) 206-525-5520
Clinicaltrials.gov
Clinical Trial Identifier
A Clinical Trial Identifier is a unique number assigned to a clinical trial by clinical trial registries around the world.